Solventum Corp reported $911M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Abbott USD 5.3B 380M Mar/2026
Align Technology USD 303.5M 60.47M Mar/2026
Baxter International USD 1.81B 587M Mar/2026
Becton, Dickinson and Co. USD 2.56B 281M Mar/2026
Cencora USD 83.12B 2.35B Dec/2025
Dexcom USD 441.6M 25.3M Mar/2026
Insulet USD 232.7M 17.5M Mar/2026
Solventum Corp USD 911M 60M Mar/2026
West Pharmaceutical Services USD 548.5M 47.4M Mar/2026
Zimmer Biomet Holdings USD 738.3M 231.8M Mar/2026